Vimarsana
Biggest News Aggregation in the World

Page 3 - Skin Study News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Skin Study. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Skin Study Today - Breaking & Trending Today

OncoBeta receives ethics approval for EPIC-Skin study to evaluate Rhenium-SCT in Australia - Vimarsana News

OncoBeta receives ethics approval for EPIC-Skin study to evaluate Rhenium-SCT in Australia

Published: December 21, 2021

/PRNewswire/ -- OncoBeta® GmbH, a medical device company specialized in innovative epidermal radioisotope therapies announced today that the company has...

Source: prnewswire.com
Related Topics:
New YorkUnited StatesNorth SydneyNew South WalesUnited KingdomSaima VohraGerhard DahlhoffShannond BrownOncobeta GmbTherapeutic Nuclear MedicineNational HealthClinical Research OrganizationResearch CouncilTherapeutic Goods AdministrationMedical Research CouncilComplete Response RateSkin StudyPersonalised IrradiationMedical DirectorSafety MonitoringClinical TrialsManaging DirectorOncobeta AustraliaPatient Reported Outcome MeasuresRoyal North Shore Hospital
OncoBeta receives ethics approval for EPIC-Skin study to evaluate Rhenium-SCT in Australia - Vimarsana News

OncoBeta receives ethics approval for EPIC-Skin study to evaluate Rhenium-SCT in Australia

Published: December 21, 2021

/PRNewswire/ -- OncoBeta® GmbH, a medical device company specialized in innovative epidermal radioisotope therapies announced today that the company has...

Source: prnewswire.com
Related Topics:
New YorkUnited StatesNorth SydneyNew South WalesUnited KingdomSaima VohraGerhard DahlhoffShannond BrownOncobeta GmbTherapeutic Nuclear MedicineNational HealthClinical Research OrganizationResearch CouncilTherapeutic Goods AdministrationMedical Research CouncilComplete Response RateSkin StudyPersonalised IrradiationMedical DirectorSafety MonitoringClinical TrialsManaging DirectorOncobeta AustraliaPatient Reported Outcome MeasuresRoyal North Shore Hospital